Last reviewed · How we verify
NCT06909578: MOCA II
Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
NA trial testing CorFlow Controlled Flow Infusion System - CoFI™ in Microvascular Obstruction (MVO) in 200 participants. Not yet recruiting.
1 December 2026
Quick facts
| Lead sponsor | CorFlow Therapeutics AG |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 200 |
| Start date | 1 September 2025 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 December 2026 |
Drugs / interventions tested
- CorFlow Controlled Flow Infusion System - CoFI™
Conditions studied
- Microvascular Obstruction (MVO) — all drugs for Microvascular Obstruction (MVO) →
- STEMI - ST Elevation Myocardial Infarction — all drugs for STEMI - ST Elevation Myocardial Infarction →
Sponsor
CorFlow Therapeutics AG
Who can join
18 and older, any sex, with Microvascular Obstruction (MVO) or STEMI - ST Elevation Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, multicenter, international single-arm, pivotal clinical study designed to validate the performance of the CoFI system in detecting MVO in STEMI subjects, as confirmed by CMRI. The study will be conducted in accordance with the Declaration of Helsinki, EN ISO 14155:2020, local and national regulations. Each study site will receive support from a sponsor-certified proctor during the learning curve to ensure consistent and accurate application of the CoFI system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06909578
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CorFlow Controlled Flow Infusion System - CoFI™
Trials testing the same drug.
- NCT03654573 — The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment · Phase 1 · completed
Other CorFlow Therapeutics AG trials
Trials by the same sponsor.
- NCT03654573 — The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06909578 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CorFlow Therapeutics AG
- Last refreshed: 10 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06909578.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing